Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
MMWR Morb Mortal Wkly Rep ; 68(29): 642-646, 2019 Jul 26.
Artigo em Inglês | MEDLINE | ID: mdl-31344023

RESUMO

The number of wild poliovirus (WPV) cases in Nigeria decreased from 1,122 in 2006 to six WPV type 1 (WPV1) in 2014 (1). During August 2014-July 2016, no WPV cases were detected; during August-September 2016, four cases were reported in Borno State. An insurgency in northeastern Nigeria had resulted in 468,800 children aged <5 years deprived of health services in Borno by 2016. Military activities in mid-2016 freed isolated families to travel to camps, where the four WPV1 cases were detected. Oral poliovirus vaccine (OPV) campaigns were intensified during August 2016-December 2017; since October 2016, no WPV has been detected (2). Vaccination activities in insurgent-held areas are conducted by security forces; however, 60,000 unvaccinated children remain in unreached settlements. Since 2018, circulating vaccine-derived poliovirus type 2 (cVDPV2) has emerged and spread from Nigeria to Niger and Cameroon; outbreak responses to date have not interrupted transmission. This report describes progress in Nigeria polio eradication activities during January 2018-May 2019 and updates the previous report (2). Interruption of cVDPV2 transmission in Nigeria will need increased efforts to improve campaign quality and include insurgent-held areas. Progress in surveillance and immunization activities will continue to be reviewed, potentially allowing certification of interruption of WPV transmission in Africa in 2020.


Assuntos
Erradicação de Doenças , Surtos de Doenças/prevenção & controle , Poliomielite/prevenção & controle , Vigilância da População , Adolescente , Criança , Pré-Escolar , Surtos de Doenças/estatística & dados numéricos , Humanos , Programas de Imunização , Lactente , Nigéria/epidemiologia , Poliomielite/epidemiologia , Poliovirus/genética , Poliovirus/isolamento & purificação , Vacinas contra Poliovirus/administração & dosagem , Avaliação de Programas e Projetos de Saúde , Sorogrupo , Violência
2.
MMWR Morb Mortal Wkly Rep ; 67(8): 253-256, 2018 Mar 02.
Artigo em Inglês | MEDLINE | ID: mdl-29494568

RESUMO

Nearly three decades after the World Health Assembly launched the Global Polio Eradication Initiative in 1988, four of the six World Health Organization (WHO) regions have been certified polio-free (1). Nigeria is one of three countries, including Pakistan and Afghanistan, where wild poliovirus (WPV) transmission has never been interrupted. In September 2015, after >1 year without any reported WPV cases, Nigeria was removed from WHO's list of countries with endemic WPV transmission (2); however, during August and September 2016, four type 1 WPV (WPV1) cases were reported from Borno State, a state in northeastern Nigeria experiencing a violent insurgency (3). The Nigerian government, in collaboration with partners, launched a large-scale coordinated response to the outbreak (3). This report describes progress in polio eradication activities in Nigeria during January-December 2017 and updates previous reports (3-5). No WPV cases have been reported in Nigeria since September 2016; the latest case had onset of paralysis on August 21, 2016 (3). However, polio surveillance has not been feasible in insurgent-controlled areas of Borno State. Implementation of new strategies has helped mitigate the challenges of reaching and vaccinating children living in security-compromised areas, and other strategies are planned. Despite these initiatives, however, approximately 130,000-210,000 (28%-45%) of the estimated 469,000 eligible children living in inaccessible areas in 2016 have not been vaccinated. Sustained efforts to optimize surveillance and improve immunization coverage, especially among children in inaccessible areas, are needed.


Assuntos
Erradicação de Doenças , Poliomielite/prevenção & controle , Vacinas contra Poliovirus/administração & dosagem , Vigilância da População , Adolescente , Criança , Pré-Escolar , Humanos , Programas de Imunização , Lactente , Nigéria/epidemiologia , Poliomielite/epidemiologia , Poliovirus/isolamento & purificação , Vacinas contra Poliovirus/efeitos adversos , Medidas de Segurança
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA